Risk factors for prostate cancer
Abstract
The incidence of prostate cancer in the United States has recently undergone dramatic and unprecedented changes. Exposure to prostate-specific antigen testing has led to a steep increase in reported incidence. The data indicate that the strongest risk factors for prostate cancer are age and African American race/ethnicity. Family history is also an important risk factor for prostate cancer, although only a small proportion of cases will be due to high-penetrance genes such as those at the putative susceptibility loci (eg, ELAC2) recently identified through linkage analysis. International variation in the risk of prostate cancer is profound, as is the frequency with which migrants from low- to high-risk areas adopt the risk pattern of the host country, possibly within a single generation. This article reviews the current state of knowledge regarding risk factors for prostate cancer, including factors related to diet, anthropometrics, hormone profiles, and concomitant medical conditions. The need for unifying, overarching hypotheses is emphasized, along with identification of some of the barriers to future progress in the field.
Figures


Similar articles
-
Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.Am J Hum Genet. 2001 Apr;68(4):901-11. doi: 10.1086/319513. Epub 2001 Mar 14. Am J Hum Genet. 2001. PMID: 11254448 Free PMC article.
-
Perspective: prostate cancer susceptibility genes.Endocrinology. 2002 Jun;143(6):2029-40. doi: 10.1210/endo.143.6.8890. Endocrinology. 2002. PMID: 12021166 Review.
-
Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):588-99. doi: 10.1158/1055-9965.EPI-09-0864. Epub 2010 Jan 19. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20086112 Free PMC article.
-
Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.J S C Med Assoc. 2006 Aug;102(7):241-9. J S C Med Assoc. 2006. PMID: 17319238 Review.
-
Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):949-57. doi: 10.1158/1055-9965.EPI-04-0637. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15824169
Cited by
-
Geospatial analysis, web-based mapping and determinants of prostate cancer incidence in Georgia counties: evidence from the 2012-2016 SEER data.BMC Cancer. 2021 May 6;21(1):508. doi: 10.1186/s12885-021-08254-0. BMC Cancer. 2021. PMID: 33957887 Free PMC article.
-
Antiproliferative effect of a synthetic aptamer mimicking androgen response elements in the LNCaP cell line.Cancer Gene Ther. 2016 Aug;23(8):254-7. doi: 10.1038/cgt.2016.26. Epub 2016 Jul 1. Cancer Gene Ther. 2016. PMID: 27364573
-
Growth factors involve in cellular proliferation, differentiation and migration during prostate cancer metastasis.Int J Cell Biol Physiol. 2019;2(1-2):1-13. Epub 2019 Oct 7. Int J Cell Biol Physiol. 2019. PMID: 32259163 Free PMC article.
-
Differential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer Progression.PLoS One. 2015 Oct 15;10(10):e0140671. doi: 10.1371/journal.pone.0140671. eCollection 2015. PLoS One. 2015. PMID: 26469707 Free PMC article.
-
Key regulators in prostate cancer identified by co-expression module analysis.BMC Genomics. 2014 Nov 24;15:1015. doi: 10.1186/1471-2164-15-1015. BMC Genomics. 2014. PMID: 25418933 Free PMC article.
References
-
- Etzioni R, Legler JM, Feuer EJ, et al. Cancer surveillance series: interpreting trends in prostate cancer-part III: quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst. 1999;91:1033–1039. - PubMed
-
- Yatani R, Chigusa I, Akazaki K, et al. Geographic pathology of latent prostatic carcinoma. Int J Cancer. 1982;29:611–616. - PubMed
-
- Tavtigian SV, Simard J, Teng DH, et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet. 1001;27:134–135. - PubMed
-
- Stanford JL, Ostrander EA. Familial prostate cancer. Epidemiol Rev. 2001;23:19–23. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources